Day: March 5, 2021

 Bank of Åland PlcManagers’ TransactionsMarch 5, 2021, 15.30 a.m.Managers’ Transactions__Person subject to the notification requirementName: Mörn, Anders MikaelPosition: Other senior managerIssuer: Ålandsbanken AbpLEI: 7437006WYM821IJ3MN73Notification type: INITIAL NOTIFICATIONReference number: 7437006WYM821IJ3MN73_20210305143910_3__Transaction date: 2021-03-05Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI0009001127Nature of the transaction: SUBSCRIPTIONTransaction details(1): Volume: 680 Unit price: 23.6 EURAggregated transactions(1): Volume: 680 Volume weighted average price: 23.6 EURFor further information, please contact:Peter Wiklöf, Managing Director and Chief Executive, tel +358 40 512 7505

 Ålandsbanken AbpTransaktioner utförda av personer i ledande ställning5.3.2021 kl. 15.30Transaktioner utförda av personer i ledande ställning__Den anmälningsskyldigaNamn: Mörn, Anders MikaelBefattning: Annan person i högsta ledningenEmittent: Ålandsbanken AbpLEI: 7437006WYM821IJ3MN73Anmälans karaktär: FÖRSTA ANMÄLANReferensnummer: 7437006WYM821IJ3MN73_20210305143910_3__Transaktionens datum: 2021-03-05Handelsplats: OFF-EXCHANGE TRANSACTIONS (XOFF)Typ av instrument: AKTIEISIN: FI0009001127Transaktionens karaktär: TECKNINGDetaljer om transaktionerna(1): Volym: 680 Enhetspris: 23,6 EURAggregerad information om transaktionerna(1): Volym: 680 Medelpris: 23,6 EURYtterligare information:Peter Wiklöf, Vd och koncernchef, Ålandsbanken Abp, tfn +358 40 512 7505

MONTRÉAL, March 05, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (“Premier Health” or the “Corporation”), a leading Canadian Healthtech company, is pleased to announce that it was awarded two five years paratransit contracts by the Government of Quebec for a total value of approximately $18M (the “Contracts”). The Contracts awarded cover the Laurentians and Lanaudière administrative regions and are expected to start in the course of 2021. The Contracts represent together an estimated 28,000 transport segments per year.Paratransit service is a non-ambulatory adapted medical transport required for specialized treatments, medical appointments and transfer between facilities in vehicles with dedicated equipment such as multi-position chairs, bariatric chairs, vital signs monitors, and central oxygen devices.The...

MONTREAL, March 05, 2021 (GLOBE NEWSWIRE) — Imperial Mining Group Ltd. (“Imperial”) (TSX VENTURE: IPG ; OTCQB: IMPNF) today announced that it has qualified to trade on the OTCQB® Venture Market, operated by OTC Markets Group Inc.Imperial Mining Group begins trading today on OTCQB under the symbol “IMPNF”. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.“On behalf of everyone at OTC Markets Group, we’re delighted to approve and welcome Imperial Mining Group to trade on the OTCQB Venture Market,” said Chris King, Senior Vice-President, Corporate Services. “Gaining access to the broader US investor and broker community is a critical step for Imperial Mining. We look forward to helping them deliver on their corporate objectives and greater US investor...

Dr. Keith Sellers selected as the winner out of 4 finalists including Dr. Tarek El-Bialy, Dr. Mike Lanzetta, and Dr. Gregory Ross, by showcasing a complex orthodontic treatment using Invisalign clear aligners at the Invisalign Virtual Ortho SummitTEMPE, Ariz., March 05, 2021 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) today announced the winner of the 2020 Invisalign Ortho Summit Case Shoot-out, one of the Company’s live case presentations during the virtual Summit. Dr. Keith Sellers of Charlotte, North Carolina received the greatest number of attendee votes for his Class II/Class III Invisalign case presentation. The Invisalign Ortho Summit Case Shoot-out program features Invisalign treatment outcomes submitted by orthodontists from across North America. Doctors with the best treatment outcomes in each of four Summit...

FLORHAM PARK, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will be available for 1×1 meetings at the following upcoming conferences:The company’s presentation is available for on-demand viewing in the link HERE.About Cellectar Biosciences, Inc.Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop PDCs that specifically...

WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that Timber’s Chief Executive Officer John Koconis will present a corporate overview at the virtual 2021 H.C. Wainwright Global Life Sciences Conference being held on March 9-10, 2021.Timber’s presentation will be available to registered conference attendees for on-demand viewing beginning March 9, 2021 at 7:00AM EST via the virtual conference link.Mr. Koconis and Joe Luchese, Chief Financial Officer, will also participate in one-on-one investor meetings with registered conference attendees throughout the conference.About...

SAN FRANCISCO and TORONTO, March 05, 2021 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the “Company” or “Claritas“) today announced the addition of Professor Salvatore Cuzzocrea, Ph.D. as an independent member of the Company’s board of directors (the “Board of Directors”), effective immediately.Dr. Cuzzocrea is an acknowledged expert in the science and clinical use of nitric oxide therapy, and his appointment to the Board of Directors will position the Company as a leader in the field of nitric oxide therapeutics.“We are delighted to add Dr. Cuzzocrea to the Company’s Board of Directors,” stated Robert Farrell, President and CEO. “We are eager to begin work with Dr. Cuzzocrea on development of R-107, our proprietary nitric oxide releasing compound that is being developed...

DENVER, March 05, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (“IONM”), is pleased to announce that it has received a loan (“Loan”) under the United States Small Business Administration’s (“SBA”) Paycheck Protection Program Second Draw Loans under the Small Business Act, Paycheck Protection Program (“PPP”), implemented pursuant to the Coronavirus Aid, Relief, and Economic Security Act.On March 2, 2021, Assure executed a PPP promissory note and received a $1,664,700 unsecured PPP loan, which matures on February 25, 2026 (the “Loan”). The Loan carries an interest rate of 1.0% per annum, with principal and interest payments due on the first day of each month, with payments commencing on the earlier of: (i) the day the...